When:
Thursday, February 29th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, March 12th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, March 26th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, April 9th, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, April 23rd, 2024 from 1pm - 3pm ET - Archival On-Demand
Tuesday, May 14th, 2024 from 1pm - 3pm ET
Tuesday, May 28th, 2024 from 1pm - 3pm ET
Tuesday, June 18th, 2024 from 1pm - 3pm ET
Tuesday, June 25th, 2024 from 1pm - 3pm ET
Tuesday, July 9th, 2024 from 1pm - 3pm ET
Tuesday, July 16th, 2024 from 1pm - 3pm ET
Tuesday, July 30th, 2024 from 1pm - 3pm ET - BONUS WEBINAR!
The Center for Forensic Science Research and Education, with support from the Centers for Disease Control and Prevention (CDC) and the National Network of Public Health Institutes (NNPHI) is pleased to offer a thought-provoking series entitled, “The Role of Comprehensive Medicolegal Death Investigation as part of a Public Health Improvement Strategy”.
This twelve-part series will feature presentations from forensic pathology, forensic toxicology, and medical toxicology experts; followed by panel discussions and interactive Q&A sessions on emerging topics and challenges in drug toxicity in death in today’s challenging illicit drug environment. The series will involve a multitude of topics relating to drug and substance poisoning deaths that pose complexities and challenges in ensuring we are collecting accurate drug death certification data. Attendees will also gain an understanding of how forensic pathologists use autopsy findings and other evidence to determine the cause and manner of death in drug-related cases.
Each webinar in this series will explore the challenges and limitations of drug death certification, including issues related to the interpretation of toxicological results, the identification of drug-related deaths, and the potential for false-positive or false-negative results. We will also be exploring the emerging topics in drug death certification, such as the use of new psychoactive substances and the impact of the opioid epidemic on drug death rates.
The content, expert presenters, and presentation dates for the series include:
Webinar 1 - The Intersection of Forensic Pathology and Public Health: Improving Outcomes with Applied Forensic Epidemiology
WHEN: FEBRUARY 29, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Abigail Grande, Western Michigan University Homer Stryeker M.D. School of Medicine, Michigan
Dr. Sarah Lathrop, University of New Mexico School of Medicine, New Mexico
Megan Broekemeier, Utah Office of the Medical Examiner, Utah
Dr. Michael Staley, Utah Office of the Medical Examiner, Utah
Webinar 2 - Fentanyl, Opioid and Polydrug Deaths in Infants and Children
WHEN: MARCH 12, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Robert Middleberg, Forensic Toxicologist at NMS Labs in Horsham, Pennsylvania
Dr. Katrina Monday, Onondaga County Medical Examiner's Office, New York
Dr. Julie Gaither, Yale School of Medicine, Connecticut
Webinar 3 - The Forensic Autopsy as the Practice of Medicine – The Public Health Value of Comprehensive Medicolegal Death Investigation
WHEN: MARCH 26, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Deland Weyrauch, Montana State Medical Examiner's Office, Montana
Dr. Reade Quinton, Southern Minnesota Regional Medical Examiner's Office and the Mayo Clinic, Minnesota
Dr. John Walsh, Armed Forces Military Examiner System, USA
Webinar 4 - NPS Discovery Updates and Trend Reports for Emerging Drugs in 2024
WHEN: APRIL 9, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Alex Krotulski, Center for Forensic Science Research and Education in Horsham, Pennsylvania
Dr. Lorenzo Gitto, Cook County Medical Examiners Office, Illinois
Donna Papsun, NMS Labs in Horsham, Pennsylvania
Webinar 5 - Veterinary Drugs and other Toxic Adulterants in the US Drug Supply
WHEN: APRIL 23, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Ed Sisco, National Institute Standards and Technology, Maryland
Dr. Lewis Nelson, Rutgers University School of Medicine in Camden, New Jersey
Dr. Barry Logan, Forensic Toxicologist and Executive Director of the CFSRE, Pennsylvania
Webinar 6 - The ToxIC Registry and Initiatives in the Medical Toxicology Community to Understand Issues in Drug Overdose, Morbidity, and Mortality
WHEN: MAY 14, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Alex Manini, Icahn School of Medicine at Mount Sinai, New York
Dr. Kim Aldy, American College of Medical Toxicology, Arizona
Sarah Walton, Center for Forensic Science Research and Education in Horsham, Pennsylvania
Webinar 7 - The Value of Prescription Drug Monitoring Programs in the United States, with Discussion of Access and Utility Challenges for Medicolegal Death Investigators
WHEN: MAY 28, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Wes Sargent, Centers for Disease Control and Prevention, Georgia
Erin Worrell, Office of the Chief Medical Examiner in Denver, Colorado
Dr. Kimberly Molina, Cheif Medical Examiner in Bexar County, Texas
Webinar 8 - Best Practices in Certification of Drug-Caused and Drug-Related Deaths: Drugs on Contributory Causes or Incidental Findings?
WHEN: JUNE 18, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Laura Labay, NMS Labs in Horsham, Pennsylvania
Dr. Jim Gill, Chief Medical Examiner for the State of Connecticut
Dr. Greg Davis, Chief Medical Examiner for Jefferson County, Alabama
Webinar 9 - SUDORS: Using Data from the Medicolegal Death Investigation Community to Inform Drug Overdose Prevention and Response
WHEN: JUNE 25, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Amanda Dinwiddie, Centers for Disease Control and Prevention, Georgia
Natalie Bladis, Department of Health and Human Services, Nevada
Matthew, Kappel, Southern Nevada Health District, Nevada
Webinar 10 - Components of Counterfeit Pills: Death Investigation, Toxicology Report, Autopsy Suite to Preventative Public Health Responses
WHEN: JULY 9, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Julie O'Donnell, Centers for Disease Control and Prevention, Georgia
Dr. Michelle Aurilius, Chief Medical Examiner for the State of North Carolina
Laura Friederich, Office of the Chief Medical Examiner, North Carolina
Sarah Shuda, Center for Forensic Science Research and Education in Horsham, Pennsylvania
Webinar 11 - Challenges in Investigation of Drug-Related Deaths in Small / Rural Jurisdictions
WHEN: JULY 16, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Tom Gilson, Chief Medical Examiner of Cuyahoga County, Ohio
Dr. John Lucas, Office of the Chief Medical Examiner San Diego, California
Dan Anderson, NMS Labs in Horsham, Pennsylvania
Dr. Jennie Duval, Office of the Chief Medical Examiner, New Hampshire
Webinar 12 - Poison Centers and NPDS: Safeguarding Public Health with Data and Expertise
WHEN: JULY 30, 2024 FROM 1 PM - 3 PM ET
PRESENTERS:
Dr. Jeanna Marraffa, Upstate New York Poison Center, New York
Dr. Michael Yeh, Centers for Disease Control and Prevention, Georgia
Dr. Alvin Bronstein, Hawaii Department of Health, Hawaii
*The webinar's content has been reviewed by the ABFT and ABC, and determined to be acceptable for submission to the ABFT or ABC for continuing education credit.
*The following statements apply to all live/virtual sessions
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and The Center for Forensic Science Research and Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Funding for this training was made possible by a cooperative agreement between the National Network of Public Health Institutes (NNPHI) and the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award (NOFO OT18-1802, titled Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health). The views expressed in training materials or by speakers and moderators in presentations do not necessarily reflect the official policies of HHS, CDC, or NNPHI, and the mention of trade names, commercial practices, or organizations does not imply endorsement by the United States government.
Click the LOGIN button below to register for the ten-part webinar series: The Role of Comprehensive Medicolegal Death Investigation as Part of a Public Health Improvement Strategy!
